| Year |
Citation |
Score |
| 2022 |
Bhatia S, Nguyen D, Darragh LB, Van Court B, Sharma J, Knitz MW, Piper M, Bukkapatnam S, Gadwa J, Bickett TE, Bhuvane S, Corbo S, Wu B, Lee Y, Fujita M, ... ... Rodriguez O, et al. EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment. Nature Communications. 13: 3535. PMID 35725568 DOI: 10.1038/s41467-022-31124-7 |
0.318 |
|
| 2020 |
Gris-Oliver A, Palafox M, Monserrat L, Brasó-Maristany F, Òdena A, Sánchez-Guixé M, Ibrahim YH, Villacampa G, Grueso J, Parés M, Guzman M, Rodriguez O, Bruna A, Hirst CS, Barnicle A, et al. Genetic alterations in the PI3K/AKT pathway and baseline AKT activity define AKT inhibitor sensitivity in breast cancer patient-derived xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32220884 DOI: 10.1158/1078-0432.Ccr-19-3324 |
0.349 |
|
| 2019 |
Ihemelandu C, Naeem A, Parasido E, Berry D, Chaldekas K, Harris BT, Rodriguez O, Albanese C. Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer. Colorectal Cancer. 8: CRC11. PMID 32038737 DOI: 10.2217/Crc-2019-0009 |
0.329 |
|
| 2019 |
Parasido E, Avetian G, Naeem A, Graham G, Pishvaian M, Glasgow E, Mudambi S, Lee Y, Ihemelandu C, Choudhry M, Peran I, Banerjee PP, Avantaggiati ML, Bryant K, Baldelli E, ... ... Rodriguez O, et al. The sustained induction of c-Myc drives nab-paclitaxel resistance in primary pancreatic ductal carcinoma cells. Molecular Cancer Research : McR. PMID 31164413 DOI: 10.1158/1541-7786.Mcr-19-0191 |
0.328 |
|
| 2018 |
Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzmán M, Rodríguez O, Grueso J, Bonache S, Moles-Fernández A, Villacampa G, et al. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Embo Molecular Medicine. PMID 30377213 DOI: 10.15252/Emmm.201809172 |
0.388 |
|
| 2018 |
Speidell AP, Demby T, Lee Y, Rodriguez O, Albanese C, Mandelblatt J, Rebeck GW. Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotoxicity Research. PMID 30284204 DOI: 10.1007/S12640-018-9954-7 |
0.326 |
|
| 2018 |
Tricoli L, Naeem A, Parasido E, Mikhaiel JP, Choudhry MU, Berry DL, Abdelgawad IA, Lee RJ, Feldman AS, Ihemelandu C, Avantaggiati M, Kumar D, Byers S, Gallagher R, Wulfkuhle J, ... ... Rodriguez O, et al. Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells. Oncotarget. 9: 2193-2207. PMID 29416764 DOI: 10.18632/Oncotarget.23363 |
0.348 |
|
| 2018 |
Galli S, Hong S, Tilan JU, Adnani M, Zhu S, Fallah Y, Lee Y, Rodriguez O, Albanese C, Izycka-Swieszewska E, Kitlinska J. Abstract B13: Perineural invasion in Ewing sarcoma—a novel mechanism and new therapeutic opportunities Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B13 |
0.429 |
|
| 2018 |
Palafox M, Herrera-Abreu MT, Bellet M, Oliveira M, Bruna A, Rodriguez O, Guzmán M, Grueso J, Vilaplana C, Arribas J, Tomaso Ed, Su F, Caldas C, Turner NC, Dienstmann R, et al. Abstract 3596: Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX) Cancer Research. 78: 3596-3596. DOI: 10.1158/1538-7445.Am2018-3596 |
0.411 |
|
| 2017 |
Tricoli LJ, Berry D, Parasido E, Naeem A, Rodriguez O, Abdelgawad I, Lee R, Feldman A, Albanese C. Abstract 4829: Development of rapid 3-dimensional culture conditions that support thein vitrodifferentiation of conditionally reprogrammed primary prostate cells for the study of prostate cancer Cancer Research. 77: 4829-4829. DOI: 10.1158/1538-7445.Am2017-4829 |
0.318 |
|
| 2017 |
Naeem A, Choudhry MU, Avantaggiati ML, Rodriguez OC, Albanese C. Abstract 3178: The p53 tumor suppressor protein paradoxically drives chemo-resistance in human medulloblastoma cells through suppressing the mTOR AKT pathway Cancer Research. 77: 3178-3178. DOI: 10.1158/1538-7445.Am2017-3178 |
0.415 |
|
| 2017 |
Hong SH, Wietlisbach L, Galli S, Mahajan A, Zhu S, Tilan J, Lee Y, Rodriguez O, Albanese C, Kitlinska J. Abstract 1940: Prenatal stress increases malignancy of neuroblastoma tumors in TH-MYCN animal model Cancer Research. 77: 1940-1940. DOI: 10.1158/1538-7445.Am2017-1940 |
0.328 |
|
| 2017 |
Gris-Oliver A, Oliveira M, Guzman M, Rodríguez O, Grueso J, Scaltriti M, Howat WJ, Barrett JC, Cortés J, Baselga J, Schiavon G, Davies BR, Saura C, Serra V. Abstract 150: Identification of determinants of sensitivity to AKT inhibition using breast cancer (BC) patient-derived tumor xenografts (PDX) Cancer Research. 77: 150-150. DOI: 10.1158/1538-7445.Am2017-150 |
0.408 |
|
| 2016 |
Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB. In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis. Journal of Visualized Experiments : Jove. PMID 28060251 DOI: 10.3791/54532 |
0.378 |
|
| 2016 |
Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. The American Journal of Pathology. PMID 27743558 DOI: 10.1016/J.Ajpath.2016.07.019 |
0.406 |
|
| 2016 |
Herrera-Abreu MT, Palafox M, Asghar U, Rivas MA, Cutts RJ, Garcia-Murillas I, Pearson A, Guzman M, Rodriguez O, Grueso J, Bellet M, Cortés J, Elliott R, Pancholi S, Baselga J, et al. Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer. Cancer Research. PMID 27020857 DOI: 10.1158/0008-5472.Can-15-0728 |
0.407 |
|
| 2016 |
Serra V, Palafox M, Herrera M, Rivas MA, Guzmán M, Rodriguez O, Grueso J, Bellet M, Oliveira M, Saura C, Tomaso Ed, Camponigro G, Turner NC, Cortés J, Baselga J. Abstract 2825: Identification of CDK4/6-response biomarkers using estrogen receptor-positive breast cancer patient-derived xenografts (PDX) Cancer Research. 76: 2825-2825. DOI: 10.1158/1538-7445.Am2016-2825 |
0.403 |
|
| 2016 |
Tilan JU, Hong S, Galli S, Acree R, Connors K, Horton M, Mahajan A, Wietlisbach L, Lee Y, Rodriguez O, Albanese C, Kitlinska J. Abstract 2478: Tumor hypoxia promotes Ewing sarcoma metastases in a mouse xenograft model Cancer Research. 76: 2478-2478. DOI: 10.1158/1538-7445.Am2016-2478 |
0.409 |
|
| 2016 |
Naeem A, Yenugonda V, Rodriguez O, Avantaggiati M, Rood B, Karam S, Albanese C. Mechanisms of p53-mediated chemosensitivity of VMY on medulloblastoma cells European Journal of Cancer. 61: S90. DOI: 10.1016/S0959-8049(16)61315-1 |
0.322 |
|
| 2015 |
Bhatia S, Hirsch K, Baig NA, Rodriguez O, Timofeeva O, Kavanagh K, Lee YC, Wang XJ, Albanese C, Karam SD. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model. Journal of Hematology & Oncology. 8: 105. PMID 26345456 DOI: 10.1186/S13045-015-0202-9 |
0.371 |
|
| 2015 |
García-García C, Rivas MA, Ibrahim YH, Calvo MT, Gris-Oliver A, Rodríguez O, Grueso J, Antón P, Guzmán M, Aura C, Nuciforo P, Jessen K, Argilés G, Dienstmann R, Bertotti A, et al. MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26272063 DOI: 10.1158/1078-0432.Ccr-14-3091 |
0.398 |
|
| 2015 |
Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, Dritschilo A, Lee YC, Henkemeyer M, Rood B, Jung M, Wang XJ, Kool M, Rodriguez O, Albanese C, et al. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget. 6: 8929-46. PMID 25879388 DOI: 10.18632/Oncotarget.3369 |
0.421 |
|
| 2015 |
Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases. Oncotarget. 6: 7151-65. PMID 25714031 DOI: 10.18632/Oncotarget.3345 |
0.313 |
|
| 2015 |
Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT. Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20. PMID 25065592 DOI: 10.1038/Onc.2014.231 |
0.34 |
|
| 2015 |
Hong S, Christian D, Trinh E, Galli S, Horton M, Lee Y, Albanese C, Rodriguez O, Tilan JU, Kitlinska J. Abstract 3291: Prenatal stress increases neuroblastoma tumorigenesis in TH-MYCN mice model Cancer Research. 75: 3291-3291. DOI: 10.1158/1538-7445.Am2015-3291 |
0.322 |
|
| 2014 |
Tian Y, Wang SS, Zhang Z, Rodriguez OC, Petricoin E, Shih IM, Chan D, Avantaggiati M, Yu G, Ye S, Clarke R, Wang C, Zhang B, Wang Y, Albanese C. Integration of network biology and imaging to study cancer phenotypes and responses. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 11: 1009-1019. PMID 25750594 DOI: 10.1109/Tcbb.2014.2338304 |
0.316 |
|
| 2014 |
Ringer L, Sirajuddin P, Tricoli L, Waye S, Choudhry MU, Parasido E, Sivakumar A, Heckler M, Naeem A, Abdelgawad I, Liu X, Feldman AS, Lee RJ, Wu CL, Yenugonda V, ... ... Rodriguez O, et al. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells. Oncotarget. 5: 10678-91. PMID 25296977 DOI: 10.18632/Oncotarget.2528 |
0.444 |
|
| 2014 |
Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI. Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells. Oncotarget. 5: 1683-98. PMID 24742967 DOI: 10.18632/Oncotarget.1849 |
0.455 |
|
| 2014 |
Kolukula VK, Sahu G, Wellstein A, Rodriguez OC, Preet A, Iacobazzi V, D'Orazi G, Albanese C, Palmieri F, Avantaggiati ML. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget. 5: 1212-25. PMID 24681808 DOI: 10.18632/Oncotarget.1831 |
0.41 |
|
| 2014 |
Baig NA, Rodriguez O, Pasquale E, Dritschilo A, Donoghue M, Timofeeva O, Albanese C, Karam SD. Role of the EphA4 and EphA7 genes in mediating the growth and aggressiveness of medulloblastoma tumors in the Smo/Smo medulloblastoma mouse model. Journal of Clinical Oncology. 32: e22137-e22137. DOI: 10.1200/Jco.2014.32.15_Suppl.E22137 |
0.326 |
|
| 2014 |
Hong S, Galli S, Tilan J, Christian D, Horton M, Rodriguez O, Albanese C, Kitlinska J. Abstract A52: In vivo model of Ewings sarcoma metastases Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A52 |
0.373 |
|
| 2014 |
Rivas MA, Ibrahim YH, Rodríguez O, Antón P, Cozar P, Gómez-Pardo P, Aura C, Haines BB, Sathyanarayanan S, Zhang T, Serra V, Baselga J. Abstract 924: Predictive biomarker identification for combined anti-mTOR and anti-IGF-1R treatment in luminal B breast cancer Cancer Research. 74: 924-924. DOI: 10.1158/1538-7445.Am2014-924 |
0.329 |
|
| 2014 |
Baig NA, Timofeeva O, Dritschilo A, Pasquale E, Kool M, Rood B, Rodriguez O, Albanese C, Karam S. Abstract 3458: Role of the EphB1 gene in mediating migration, proliferation, and radiosensitization of medulloblastoma cells Cancer Research. 74: 3458-3458. DOI: 10.1158/1538-7445.Am2014-3458 |
0.453 |
|
| 2014 |
Baig N, Timofeeva O, Zhao X, Dritschilo A, Pasquale E, Henkemeyer M, Kool M, Rood B, Jung M, Rodriguez O, Albanese C, Karam S. EphB1 Inhibits Migration and Proliferation of Medulloblastoma Tumor Cells and Sensitizes Them to Ionizing Radiation by Mediating a G1 Arrest International Journal of Radiation Oncology*Biology*Physics. 90: S36. DOI: 10.1016/J.Ijrobp.2014.05.150 |
0.347 |
|
| 2013 |
Albanese C, Rodriguez OC, VanMeter J, Fricke ST, Rood BR, Lee Y, Wang SS, Madhavan S, Gusev Y, Petricoin EF, Wang Y. Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges. The American Journal of Pathology. 182: 312-8. PMID 23219428 DOI: 10.1016/J.Ajpath.2012.09.024 |
0.332 |
|
| 2013 |
Serra V, Eichhorn PJ, García-García C, Ibrahim Y, Prudkin L, Rodríguez O, Marlow S, Prat A, Hahn WC, Baselga J. Abstract 4452: p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer. Cancer Research. 73: 4452-4452. DOI: 10.1158/1538-7445.Am2013-4452 |
0.386 |
|
| 2012 |
Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, Reynoso K, Bargonetti J, Wellstein A, Albanese C, Avantaggiati ML. Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle (Georgetown, Tex.). 11: 4436-46. PMID 23151455 DOI: 10.4161/Cc.22778 |
0.34 |
|
| 2012 |
Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E, et al. Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle (Georgetown, Tex.). 11: 3801-9. PMID 22983062 DOI: 10.4161/Cc.21988 |
0.36 |
|
| 2012 |
Tilan JU, Izycka-Swieszewska E, Earnest JP, Galli S, Shabbir A, Lu C, Czarnecka M, Rodriguez O, Albanese C, Kitlinska J. Abstract LB-186: Differential effects of stress on tumor initiation and progression - role of neuropeptide Y Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-186 |
0.358 |
|
| 2012 |
Sirajuddin P, Das S, Ringer L, Salinas P, Rodriguez O, Moasser B, Yenugonda VM, Albanese C, Brown M. Abstract 4774: LC-MS/MS detection of the dansyl-modified biologically active CDK inhibitor VMY-1-103 using an in vivo model system Cancer Research. 72: 4774-4774. DOI: 10.1158/1538-7445.Am2012-4774 |
0.321 |
|
| 2012 |
Ringer L, Sirajuddin P, Yenugonda VM, Brown M, Rodriguez O, Albanese C. Abstract 3052: Role of p53 in cdk inhibitor VMY-1-103-induced apoptosis in prostate cancer Cancer Research. 72: 3052-3052. DOI: 10.1158/1538-7445.Am2012-3052 |
0.428 |
|
| 2011 |
Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM, Brown ML, Toretsky JA, Uren A, Lee Y, MacDonald TJ, Rodriguez O, Glazer RI, Schlegel R, Albanese C. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biology & Therapy. 12: 818-26. PMID 21885916 DOI: 10.4161/Cbt.12.9.17682 |
0.427 |
|
| 2011 |
Kang HJ, Hong YB, Kim HJ, Rodriguez OC, Nath RG, Tilli EM, Albanese C, Chung FL, Kwon SH, Bae I. Detoxification: a novel function of BRCA1 in tumor suppression? Toxicological Sciences : An Official Journal of the Society of Toxicology. 122: 26-37. PMID 21507987 DOI: 10.1093/Toxsci/Kfr089 |
0.379 |
|
| 2011 |
Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC, Peaceman D, Ozdemirli M, Rodriguez O, Macdonald TJ, Albanese C, Toretsky JA, Uren A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. The Journal of Clinical Investigation. 121: 148-60. PMID 21183792 DOI: 10.1172/Jci42874 |
0.447 |
|
| 2010 |
Pollock CB, Rodriguez O, Martin PL, Albanese C, Li X, Kopelovich L, Glazer RI. Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation. Ppar Research. 2010: 571783. PMID 21318167 DOI: 10.1155/2010/571783 |
0.375 |
|
| 2010 |
Ringer L, Sirajuddin P, Yenugonda VM, Ghosh A, Divito K, Trabosh V, Patel Y, Brophy A, Grindrod S, Lisanti MP, Rosenthal D, Brown ML, Avantaggiati ML, Rodriguez O, Albanese C. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells. Cancer Biology & Therapy. 10: 320-5. PMID 20574155 DOI: 10.4161/Cbt.10.4.12208 |
0.437 |
|
| 2010 |
Vissapragada S, Ghosh A, Ringer L, Salinas P, Brophy A, Peaceman D, Kallakury B, Banerjee PP, Fricke ST, Helfrich W, Lee YC, Pestell R, Scherer P, Tanowitz HB, Avantaggiati ML, ... ... Rodriguez OC, et al. Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle (Georgetown, Tex.). 9: 1824-9. PMID 20404514 DOI: 10.4161/Cc.9.9.11542 |
0.312 |
|
| 2010 |
Sahu G, Rodriguez OC, Kolukula V, Catania J, Preet A, Arshed A, Albanese C, Avantaggiati ML. Abstract 66: Corruption of the activity of the mitochondria citrate transporter, CIC, by mutant forms of p53 Cancer Research. 70: 66-66. DOI: 10.1158/1538-7445.Am10-66 |
0.407 |
|
| 2010 |
Rodriguez OC, Kokula V, Catania J, Preet A, Arshed A, Pishvaian M, Albanese C, Avantaggiati ML. Abstract 4833: Glucose restriction induces degradation of p53 mutants via a selective autophagy-mediated pathway Cancer Research. 70: 4833-4833. DOI: 10.1158/1538-7445.Am10-4833 |
0.366 |
|
| 2010 |
Elizalde VS, Russillo M, Scaltriti M, Rodriguez O, Guzman M, Cosimo SD, Baselga J. Abstract 4477: Dual-targeting of AMPK and PI3K/mTOR in a panel of breast cancer cell lines Cancer Research. 70: 4477-4477. DOI: 10.1158/1538-7445.Am10-4477 |
0.415 |
|
| 2010 |
Beauchamp EM, Rodriguez O, Albanese C, Toretsky JA, Üren A. Abstract 3409: Arsenic trioxide inhibits Ewing sarcoma growth by blocking Hedgehog/GLI pathway Cancer Research. 70: 3409-3409. DOI: 10.1158/1538-7445.Am10-3409 |
0.425 |
|
| 2009 |
Rodriguez OC, Lai EW, Vissapragada S, Cromelin C, Avetian M, Salinas P, Ramos H, Kallakury B, Casimiro M, Lisanti MP, Tanowitz HB, Pacak K, Glazer RI, Avantaggiati M, Albanese C. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. The American Journal of Pathology. 174: 2051-60. PMID 19443706 DOI: 10.2353/Ajpath.2009.080859 |
0.418 |
|
| 2009 |
Elizalde VS, Eichhorn PJ, Scaltriti M, Prudkin L, Rodriguez O, Guzman M, Baselga J. Abstract B144: NVP‐BEZ235, a dual inhibitor of PI3K and mTOR, induces MAPK phosphorylation in HER2‐positive cells Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B144 |
0.369 |
|
| 2007 |
Lai EW, Rodriguez OC, Aventian M, Cromelin C, Fricke ST, Martiniova L, Lubensky IA, Lisanti MP, Picard KL, Powers JF, Tischler AS, Pacak K, Albanese C. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice. Cell Cycle (Georgetown, Tex.). 6: 1946-50. PMID 17671425 DOI: 10.4161/Cc.6.15.4521 |
0.393 |
|
| 2007 |
Casimiro M, Rodriguez O, Pootrakul L, Aventian M, Lushina N, Cromelin C, Ferzli G, Johnson K, Fricke S, Diba F, Kallakury B, Ohanyerenwa C, Chen M, Ostrowski M, Hung MC, et al. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. Cancer Research. 67: 4364-72. PMID 17483350 DOI: 10.1158/0008-5472.Can-06-1898 |
0.42 |
|
| 2006 |
Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. The Prostate. 66: 708-17. PMID 16425198 DOI: 10.1002/Pros.20392 |
0.345 |
|
| 2006 |
Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle (Georgetown, Tex.). 5: 113-9. PMID 16340310 DOI: 10.4161/Cc.5.1.2295 |
0.395 |
|
| 2005 |
Albanese C, Rodriguez O, Johnson MD, Fricke S. Models of prostate cancer Drug Discovery Today: Disease Models. 2: 7-13. DOI: 10.1016/J.Ddmod.2005.05.002 |
0.329 |
|
| 2003 |
Tirado OM, Martinez ED, Rodriguez OC, Danielsen M, Selva DM, Reventós J, Munell F, Suárez-Quian CA. Methoxyacetic acid disregulation of androgen receptor and androgen-binding protein expression in adult rat testis. Biology of Reproduction. 68: 1437-46. PMID 12606434 DOI: 10.1095/Biolreprod.102.004937 |
0.668 |
|
| 1999 |
List HJ, Smith CL, Rodriguez O, Danielsen M, Riegel AT. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: An explanation for trichostatin a effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter Experimental Cell Research. 252: 471-478. PMID 10527637 DOI: 10.1006/Excr.1999.4638 |
0.583 |
|
| Show low-probability matches. |